JAGSNPHARM JAGSNPHARM — Smart-Money Activity, F&O Buildup & Bulk Deals
Sector: UnknownJAGSNPHARM Chart daily candles · add any indicator · computed in your browser
Loading chart…
Daily bars from exchange end-of-day data; during market hours today’s bar updates with the latest price. Splits and bonuses are adjusted; demergers show as the real gaps they were. Volume profile is estimated from each day’s range. D marks a bulk or block deal day (green: net buying, red: net selling, purple: matched cross). Charting by TradingView Lightweight Charts.
Live setups screens JAGSNPHARM is on right now — tap to see every stock matching
Smart Money Verdict synthesis of derivatives, deals, and promoter files
Analysis what the data is telling us about JAGSNPHARM
JAGSNPHARM did not have meaningful F&O activity in the last completed session. That doesn't mean the stock is irrelevant — it just means the smart-money signals here come from cash markets and corporate disclosures, covered below.
There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in JAGSNPHARM over the last 30 sessions.
Putting it together, the smart-money picture for JAGSNPHARM is balanced between accumulation and distribution forces.
F&O Positioning EOD derivatives setup
Quote Details key metrics & weights
Technical Snapshot from 246 sessions of price history
Key Fundamentals headline ratios · Healthcare
Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.
Institutional Deals last 30 sessions (bulk & block)
| Date | Side | Price | Value (Cr) | Counterparty |
|---|---|---|---|---|
| 2026-07-30 | SELL | ₹ 249.89 | 15.20 | NK SECURITIES RESEARCH PRIVATE LIMITED |
| 2026-07-30 | BUY | ₹ 249.74 | 15.19 | NK SECURITIES RESEARCH PRIVATE LIMITED |
| 2026-07-30 | SELL | ₹ 252.00 | 14.87 | MICROCURVES TRADING PRIVATE LIMITED |
| 2026-07-30 | BUY | ₹ 251.82 | 14.86 | MICROCURVES TRADING PRIVATE LIMITED |
| 2026-07-30 | SELL | ₹ 250.61 | 10.33 | SILVERLEAF CAPITAL SERVICES PRIVATE LIMITED |
| 2026-07-30 | BUY | ₹ 250.43 | 10.33 | SILVERLEAF CAPITAL SERVICES PRIVATE LIMITED |
| 2026-07-30 | SELL | ₹ 254.43 | 8.38 | BLITZQUANT RESEARCH LLP |
| 2026-07-30 | BUY | ₹ 254.30 | 8.37 | BLITZQUANT RESEARCH LLP |
| 2026-06-30 | SELL | ₹ 254.53 | 16.75 | NK SECURITIES RESEARCH PRIVATE LIMITED |
| 2026-06-30 | BUY | ₹ 254.37 | 16.74 | NK SECURITIES RESEARCH PRIVATE LIMITED |
Insider & Promoter Filings last 60 days
Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others
JAGSNPHARM — frequently asked questions
What is the JAGSNPHARM share price today?
JAGSNPHARM is trading at ₹217.67 (-0.32% vs previous close), per the latest update on this page.
What is the P/E ratio of JAGSNPHARM?
JAGSNPHARM (JAGSNPHARM) has a trailing twelve-month P/E ratio of 32.4.
What is the market cap of JAGSNPHARM?
JAGSNPHARM has a market capitalisation of approximately ₹1,438 crore.
Is JAGSNPHARM near its 52-week high?
JAGSNPHARM is trading -16.1% from its 52-week high of ₹260.15.
What is the RSI of JAGSNPHARM?
The 14-day RSI of JAGSNPHARM is 36.8, which is considered neutral.
Is JAGSNPHARM above its 200-day moving average?
JAGSNPHARM is trading above its 200-DMA of ₹203.91 (+7.1% away).
Are FIIs or big investors buying JAGSNPHARM?
Strota tracks every bulk and block deal in JAGSNPHARM with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.